Generic placeholder image

Current Women`s Health Reviews

Author(s): Benedict T. Adeyanju, Babatunde A. Olofinbiyi, Idowu P. Ade-Ojo and Oluwaseyi A. Akpor*

DOI: 10.2174/0115734048258768231101080614

DownloadDownload PDF Flyer Cite As
A 5-Year Audit of the Use of Sub-dermal Implants Contraceptives in a Teaching Hospital in Ekiti State, Nigeria

Article ID: e130424228876 Pages: 6

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: The scientific community has developed non-biodegradable progestational sub-dermal implants as a response to the need of some women for long-acting contraceptives that are effective and safe.

Aim: The aim of the study was to describe the socio-demographic characteristics of women who received the implant and explore the side effects and reason for discontinuation of subdermal implant. Method: A retrospective audit of all the clients who opted for contraceptive implants between January 1st, 2011, to December 31st, 2015, was carried out. This was done by a senior registrar in the Department of Obstetrics and Gynaecology from the clinic register. The card numbers of all the clients who agreed to use contraceptive implants were identified (589), and their case records were retrieved from the records unit and family planning clinics. Only JadelleR and Implanon were available in the clinic during the period of study. Using a proforma, information regarding the clients’ age, religion, place of residence, level of education, observed side effects, and reason for discontinuation was obtained.

Results: The socio-demographic characteristics of the sub-dermal contraceptive implant acceptors revealed that the age range of clients was between 16 to 49 years. Acceptance was highest among the age group of 31-40 years (343; 58.2%). The various complications recorded revealed that most (527; 89.5%) of the clients reported no complication, while 3.4% (20) had increased menstrual flow and 2.7% (16) had menorrhagia. There was a significant association between educational qualification (X2=25.733, p=0.041), age (X2= 23.657, p= 0.001), parity (X2=81.264, p=0.001), and discontinuation of the implant.

Conclusion: The study findings revealed an increase in the sub-dermal contraceptive implant uptake. This may be due to its longevity. With adequate pre- and post-insertion counselling, the continuation rate could be increased.

Keywords: Sub-dermal implant, acceptor characteristic, continuation rate, contraceptive, pregnancy, progestational.

Graphical Abstract

[1]
Olaleye, A.O.; Akintayo, A.A.; Adewoyin, Y.O. Utilization of family planning services in a Nigerian tertiary hospital: A six year review. Trop. J. Obstet. Gynaecol., 2014, 31(2), 7-15.
[2]
Abe, E.; Omo-Aghoja, L.O. Maternal mortality at the Central Hospital, Benin City Nigeria: A ten year review. Afr. J. Reprod. Health, 2008, 12(3), 17-26.
[PMID: 19435010]
[3]
Maternal and reproductive health, World Health Organization (WHO). 2010. Available from: http://www. who. int/reproductivehealth/publications/maternal_mortality_2005/index. html
[4]
Abiodun, O.M.; Balogun, O.R. Sexual activity and contraceptive use among young female students of tertiary educational institutions in Ilorin, Nigeria. Contraception, 2009, 79(2), 146-149.
[http://dx.doi.org/10.1016/j.contraception.2008.08.002] [PMID: 19135573]
[5]
Oye-Adeniran, B.A.; Adewole, I.F.; Umoh, A.V.; Ekanem, E.E.; Gbadegesin, A.; Iwere, N. Community-based survey of unwanted pregnancy in southwestern Nigeria. Afr. J. Reprod. Health, 2004, 8(3), 103-115.
[http://dx.doi.org/10.2307/3583397] [PMID: 17348329]
[6]
Oriji, V.O.; Jeremiah, I.; Kasso, T. Induced abortionamongst undergraduate students of University of Port Harcourt. Niger. J. Med., 2009, 18(2), 199-202.
[http://dx.doi.org/10.4314/njm.v18i2.45065] [PMID: 19630330]
[7]
Stover, J.; Ross, J. How increased contraceptive use has reduced maternal mortality. Matern. Child Health J., 2010, 14(5), 687-695.
[http://dx.doi.org/10.1007/s10995-009-0505-y] [PMID: 19644742]
[8]
Okonofua, F. Need to intensify safe motherhood interventions in Africa. Afr. J. Reprod. Health, 2003, 7(3), 7-12.
[http://dx.doi.org/10.2307/3583283] [PMID: 15055141]
[9]
Bankole, A.; Oye-Adeniran, B.; Wulf, D.; Hussain, R.; Sedgh, G.; Singh, S.; Adewole, I. Unintended Pregnancy and Induced Abortion in Burkina Faso: Causes and Consequences; Guttmacher Institute: New York, 2013.
[10]
Nigeria Demographic and Health Survey (NDHS) 2013; National Population Commission: Abuja, Nigeria, 2013.
[11]
Orji, E.O.; Onwudiegwu, U. Prevalence and determinants of contraceptive practice in a defined Nigerian population. J. Obstet. Gynaecol., 2002, 22(5), 540-543.
[http://dx.doi.org/10.1080/0144361021000003126] [PMID: 12521426]
[12]
Ozumba, B.C.; ObI, S.N.; Ijioma, N.N. Knowledge, attitude and practice of modern contraception among single women in a rural and urban community in Southeast Nigeria. J. Obstet. Gynaecol., 2005, 25(3), 292-295.
[http://dx.doi.org/10.1080/01443610500105498] [PMID: 16147740]
[13]
Otoide, V.O.; Oronsaye, F.; Okonofua, F.E. Why Nigerian adolescents seek abortion rather than contraception: Evidence from focus-group discussions. Int. Fam. Plan. Perspect., 2001, 27(2), 77-81.
[http://dx.doi.org/10.2307/2673818]
[14]
Sudhinaraset, M. Reducing unsafe abortion in Nigeria. Issues Brief, 2008, 2008(3), 1-3.
[15]
Omo-Aghoja, L.O.; Omo-Aghoja, V.W.; Aghoja, C.O.; Okonofua, F.E.; Aghedo, O.; Umueri, C.; Otayohwo, R.; Feyi-Waboso, P.; Onowhakpor, E.A.; Inikori, K.A. Factors associated with the knowledge, practice and perceptions of contraception in rural southern Nigeria. Ghana Med. J., 2009, 43(3), 115-121.
[PMID: 20126323]
[16]
Monjok, E.; Smesny, A.; Ekabua, J.E.; Essien, E.J. Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions. Open Access J. Contracept., 2010, 1(1), 9-22.
[http://dx.doi.org/10.2147/OAJC.S9281]
[17]
Ladipo, O.A.; Akinso, S.A. Contraceptive implants. Afr. J. Reprod. Health, 2005, 9(1), 16-23.
[http://dx.doi.org/10.2307/3583156] [PMID: 16104651]
[18]
Folkman, J.; Long, D.M. The use of silicone rubber as a carrier for prolonged drug therapy. J. Surg. Res., 1964, 4(3), 139-142.
[http://dx.doi.org/10.1016/S0022-4804(64)80040-8] [PMID: 14130164]
[19]
Chez, R.A. Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimate. Am. J. Obstet. Gynecol., 1989, 160(5), 1296-1300.
[http://dx.doi.org/10.1016/S0002-9378(89)80016-X] [PMID: 2524163]
[20]
Abasiattai, A.; Utuk, N.; Inyang-Etoh, E. Subdermal contraceptive implants: profile of acceptors in a tertiary hospital in southern Nigeria. International Journal of Gynecology. Int. J. Gynecol. Obstet. & Neona, 2014, 1(1), 9-13.
[http://dx.doi.org/10.15379/2408-9761.2014.01.01.3]
[21]
Sivin, I.; Daniel, R. Daniel R. Mishell, Jr, MD, and the journal Contraception. Eur. J. Contracept. Reprod. Health Care, 2012, 17(6), 399-401.
[http://dx.doi.org/10.3109/13625187.2012.735294] [PMID: 23157702]
[22]
Madugu, N.H.; Abdul, M.A.; Bawa, U.; Kolawole, B. Uptake of hormonal implants contraceptive in Zaria, Northern Nigeria. Open J. Obstet. Gynecol., 2015, 5(5), 268-273.
[http://dx.doi.org/10.4236/ojog.2015.55039]
[23]
Igwe, N.; Nnamdi, E.; Jude, A. A 5-year clinical evaluation of subdermal implants among Abakaliki acceptors. J. Basic Clin. Reprod. Sci., 2016, 5(1), 1-5.
[http://dx.doi.org/10.4103/2278-960X.175730]
[24]
Moray, K.V.; Chaurasia, H.; Sachin, O.; Joshi, B. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant. Reprod. Health, 2021, 18(1), 4.
[http://dx.doi.org/10.1186/s12978-020-01054-y] [PMID: 33407632]
[25]
Coukell, A.J.; Balfour, J.A. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability. Drugs, 1998, 55(6), 861-887.
[http://dx.doi.org/10.2165/00003495-199855060-00019] [PMID: 9617600]
[26]
Rocca, M.L.; Palumbo, A.R.; Visconti, F.; Di Carlo, C. Safety and benefits of contraceptives implants: A systematic review. Pharmaceuticals, 2021, 14(6), 548.
[http://dx.doi.org/10.3390/ph14060548] [PMID: 34201123]
[27]
Pam, V.C.; Mutihir, J.T.; Nyango, D.D.; Shambe, I.; Egbodo, C.O.; Karshima, J.A. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria. Niger. Med. J., 2016, 57(6), 314-319.
[http://dx.doi.org/10.4103/0300-1652.193855] [PMID: 27942097]
[28]
Bahamondes, L.; Fernandes, A.; Monteiro, I.; Bahamondes, M.V. Long-acting reversible contraceptive (LARCs) methods. Best Pract. Res. Clin. Obstet. Gynaecol., 2020, 66, 28-40.
[http://dx.doi.org/10.1016/j.bpobgyn.2019.12.002] [PMID: 32014434]